CA3286798A1 - Markers of endometrial cancer - Google Patents
Markers of endometrial cancerInfo
- Publication number
- CA3286798A1 CA3286798A1 CA3286798A CA3286798A CA3286798A1 CA 3286798 A1 CA3286798 A1 CA 3286798A1 CA 3286798 A CA3286798 A CA 3286798A CA 3286798 A CA3286798 A CA 3286798A CA 3286798 A1 CA3286798 A1 CA 3286798A1
- Authority
- CA
- Canada
- Prior art keywords
- markers
- endometrial cancer
- endometrial
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/908—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
- G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
- G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Reproductive Health (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16168328 | 2016-05-04 | ||
| EP16168328.9 | 2016-05-04 | ||
| CA3022586A CA3022586A1 (en) | 2016-05-04 | 2017-03-30 | Markers of endometrial cancer |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3022586A Division CA3022586A1 (en) | 2016-05-04 | 2017-03-30 | Markers of endometrial cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3286798A1 true CA3286798A1 (en) | 2025-10-30 |
Family
ID=56096908
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3286798A Pending CA3286798A1 (en) | 2016-05-04 | 2017-03-30 | Markers of endometrial cancer |
| CA3022586A Pending CA3022586A1 (en) | 2016-05-04 | 2017-03-30 | Markers of endometrial cancer |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3022586A Pending CA3022586A1 (en) | 2016-05-04 | 2017-03-30 | Markers of endometrial cancer |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20190137499A1 (https=) |
| EP (3) | EP3452829B1 (https=) |
| JP (3) | JP7240712B2 (https=) |
| AU (3) | AU2017260806B9 (https=) |
| CA (2) | CA3286798A1 (https=) |
| DK (1) | DK3452829T3 (https=) |
| ES (1) | ES2974307T3 (https=) |
| FI (1) | FI3452829T3 (https=) |
| PL (1) | PL3452829T3 (https=) |
| PT (1) | PT3452829T (https=) |
| WO (1) | WO2017190896A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI3655778T3 (fi) * | 2017-07-21 | 2023-08-09 | Fundacio Hospital Univ Vall Dhebron Institut De Recerca | Agriini endometriumsyövän markkerina |
| EP4373973A1 (en) | 2021-07-23 | 2024-05-29 | Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca | Biomarkers for endometrial cancer |
| CN113493838B (zh) * | 2021-09-06 | 2021-11-23 | 北京泱深生物信息技术有限公司 | 子宫内膜癌相关的标志分子及其在诊断子宫内膜癌中的应用 |
| KR102640230B1 (ko) * | 2021-09-24 | 2024-02-22 | 가천대학교 산학협력단 | C-peptide를 처리한 자궁내막 기질세포의 이동성 변화 기작을 이용한 자궁내막 관련질환의 진단 방법 및 자궁내막 관련질환 치료제의 스크리닝 방법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
| AUPO573697A0 (en) | 1997-03-20 | 1997-04-10 | Prince Henry's Institute Of Medical Research | Diagnosis of endometrial cancer |
| AU2004303448A1 (en) * | 2003-12-23 | 2005-07-07 | Mount Sinai Hospital | Methods for detecting markers associated with endometrial disease or phase |
| WO2008003024A2 (en) | 2006-06-28 | 2008-01-03 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Method and composition for diagnosing endometrial cancer |
| EP2087152B1 (en) * | 2006-10-27 | 2015-03-11 | Walfish, Paul | Endometrial biomarkers |
| US9046522B2 (en) | 2009-07-24 | 2015-06-02 | Geadic Biotec, Aie | Markers for endometrial cancer |
-
2017
- 2017-03-30 EP EP17713973.0A patent/EP3452829B1/en active Active
- 2017-03-30 AU AU2017260806A patent/AU2017260806B9/en active Active
- 2017-03-30 WO PCT/EP2017/057635 patent/WO2017190896A1/en not_active Ceased
- 2017-03-30 DK DK17713973.0T patent/DK3452829T3/da active
- 2017-03-30 JP JP2018557905A patent/JP7240712B2/ja active Active
- 2017-03-30 ES ES17713973T patent/ES2974307T3/es active Active
- 2017-03-30 PL PL17713973.0T patent/PL3452829T3/pl unknown
- 2017-03-30 PT PT177139730T patent/PT3452829T/pt unknown
- 2017-03-30 CA CA3286798A patent/CA3286798A1/en active Pending
- 2017-03-30 FI FIEP17713973.0T patent/FI3452829T3/fi active
- 2017-03-30 EP EP23150361.6A patent/EP4180814B1/en active Active
- 2017-03-30 EP EP25190526.1A patent/EP4610655A3/en active Pending
- 2017-03-30 US US16/098,813 patent/US20190137499A1/en not_active Abandoned
- 2017-03-30 CA CA3022586A patent/CA3022586A1/en active Pending
-
2022
- 2022-11-09 US US17/984,197 patent/US20230221323A1/en not_active Abandoned
-
2023
- 2023-01-13 JP JP2023003700A patent/JP7492287B2/ja active Active
- 2023-08-02 AU AU2023210591A patent/AU2023210591B9/en active Active
-
2024
- 2024-05-10 JP JP2024077227A patent/JP7797770B2/ja active Active
-
2025
- 2025-09-01 AU AU2025223935A patent/AU2025223935A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PL3452829T3 (pl) | 2024-05-20 |
| WO2017190896A1 (en) | 2017-11-09 |
| AU2025223935A1 (en) | 2025-09-18 |
| BR112018072498A2 (pt) | 2019-03-12 |
| EP4180814C0 (en) | 2026-03-04 |
| AU2017260806B9 (en) | 2023-07-20 |
| ES2974307T3 (es) | 2024-06-26 |
| EP4610655A3 (en) | 2025-12-10 |
| JP7240712B2 (ja) | 2023-03-16 |
| US20190137499A1 (en) | 2019-05-09 |
| AU2017260806A1 (en) | 2018-12-13 |
| JP2024116127A (ja) | 2024-08-27 |
| AU2023210591B2 (en) | 2025-06-26 |
| PT3452829T (pt) | 2024-03-22 |
| CA3022586A1 (en) | 2017-11-09 |
| FI3452829T3 (fi) | 2024-03-20 |
| EP4180814B1 (en) | 2026-03-04 |
| EP4610655A2 (en) | 2025-09-03 |
| JP7492287B2 (ja) | 2024-05-29 |
| JP2019516104A (ja) | 2019-06-13 |
| JP2023040246A (ja) | 2023-03-22 |
| JP7797770B2 (ja) | 2026-01-14 |
| AU2023210591A1 (en) | 2023-08-24 |
| EP4180814A3 (en) | 2023-07-12 |
| DK3452829T3 (da) | 2024-03-25 |
| AU2023210591B9 (en) | 2025-07-10 |
| US20230221323A1 (en) | 2023-07-13 |
| AU2017260806B2 (en) | 2023-06-15 |
| EP3452829A1 (en) | 2019-03-13 |
| EP4180814A2 (en) | 2023-05-17 |
| EP3452829B1 (en) | 2024-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3248013A4 (en) | Cancer markers and methods of use thereof | |
| EP3152333A4 (en) | Methylated markers for colorectal cancer | |
| EP3132058A4 (en) | Markers for ovarian cancer and the uses thereof | |
| EP3207161A4 (en) | Methods and compositions for correlating genetic markers with cancer risk | |
| EP3164194A4 (en) | Dickkopf2 (Dkk2) Inhibition Suppresses Tumor Formation | |
| EP3828273A4 (en) | TUMOR MARKER BASED ON STAMP-EP2 METHYLATION MODIFICATION | |
| PT3655778T (pt) | Agrin como marcador de cancro do endométrio | |
| EP3245298A4 (en) | Biomarkers for colorectal cancer related diseases | |
| EP3124621A4 (en) | Mitochondrial markers of neurodegenerative diseases | |
| EP3250708A4 (en) | Biomarkers for colorectal cancer related diseases | |
| EP3904516A4 (en) | TUMOR MARKER BASED ON STAMP-EP6 METHYLATION MODIFICATION | |
| EP3415863A4 (en) | MARKER | |
| CA3286798A1 (en) | Markers of endometrial cancer | |
| EP3468578A4 (en) | USES OF IL-41 | |
| EP3347051A4 (en) | SEQUENCING SELECTING TUMOR THEROSTICAS | |
| EP3298172A4 (en) | Determining risk of prostate cancer recurrence | |
| EP3102423A4 (en) | Marker | |
| EP3424671A4 (en) | MARKER PEN | |
| EP3184635A4 (en) | Cancer marker and cancer determination method | |
| EP3652541A4 (en) | COMBINATION OF MARKERS FOR DIAGNOSING CANCER | |
| EP3194625A4 (en) | Kit for cancer detection | |
| EP3250676A4 (en) | Biomarkers for colorectal cancer related diseases | |
| EP3540367A4 (en) | MARKER | |
| EP3540369A4 (en) | MARKER | |
| EP3470771A4 (en) | MARKER PEN |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A16 | Divisional, continuation or continuation in part application filed |
Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A16-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION RECEIVED - DIVISIONAL Effective date: 20250922 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20250922 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 7TH ANNIV.) - STANDARD Year of fee payment: 7 Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD Year of fee payment: 2 Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD Year of fee payment: 6 Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 8TH ANNIV.) - STANDARD Year of fee payment: 8 Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD Year of fee payment: 5 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250922 Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST TO REGISTER A DOCUMENT RECEIVED Effective date: 20250922 |
|
| A18 | Application divided or continuation or continuation in part accepted |
Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A18-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DIVISIONAL REQUIREMENTS DETERMINED COMPLIANT Effective date: 20251009 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20251009 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20251009 |
|
| A00 | Application filed |
Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A00-A102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: COMPLIANCE REQUIREMENTS DETERMINED MET Effective date: 20251016 |
|
| P18 | Priority claim added or amended |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P18-P105 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIORITY CLAIM REQUIREMENTS DETERMINED COMPLIANT Effective date: 20251016 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20251016 Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REGISTER A DOCUMENT REQUIREMENTS DETERMINED COMPLIANT Effective date: 20251016 |
|
| Q12 | Application published |
Free format text: ST27 STATUS EVENT CODE: A-1-1-Q10-Q12-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION PUBLISHED (OPEN TO PUBLIC INSPECTION) Effective date: 20251030 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20251124 |
|
| P22 | Classification modified |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P22-P110 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CLASSIFICATION MODIFIED Effective date: 20251124 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 9TH ANNIV.) - STANDARD Year of fee payment: 9 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260310 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260310 |